- Fund Type: ETF
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
Powershares Dynamic Pharmaceuticals Portfolio
+ Add to WatchlistPJP:US
43.3200 USD 0.2400 0.56%As of 20:04:05 ET on 05/23/2013.
Snapshot for Powershares Dynamic Pharmaceuticals Portfolio (PJP)
| Open: | 42.5900 | High - Low: | 43.4394 - 42.5000 | Primary Exchange: | NYSE Arca |
|---|---|---|---|---|---|
| Volume: | 157,718 | 52-Week Range: | 30.0900 - 44.0200 | Beta vs DZRTR: | - |
Fund Profile & Information for PJP
PowerShares Dynamic Pharmaceuticals Portfolio is an exchange-traded funds incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Pharamaceuticals Intellidex Index, which thoroughly evaluates based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
| Inception Date: | 2005-06-23 | Telephone: | 1-800-983-0903 |
|---|---|---|---|
| Managers: | PETER HUBBARD | ||
| Web Site: | www.powershares.com | ||
Fundamentals for PJP
| NAV | (on 2013-05-23) 43.2696 |
|---|---|
| Assets (M) | (on 2013-04-30) 468.2800 |
| Shares out (M) | 12.00 |
| Market Cap (M) | 519.84 |
| % Premium | 0.12 |
| Average 52-Week % Premium | 0.0371 |
| Fund Leveraged | N |
Dividends for PJP
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-03-15) 0.0100 |
| Dividend Yield (ttm) | 1.25% |
Performance for PJP
| 1-Month | +4.99% | 1-Year | +43.33% |
|---|---|---|---|
| 3-Month | +15.30% | 3-Year | +34.70% |
| Year To Date | +25.49% | 5-Year | +21.63% |
| Expense Ratio | 0.63 |
Top Fund Holdings for PJP
Filing Date: 05/20/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 521,566 | 29,072,089 | 5.763% |
| Bristol-Myers Squibb Co | 600,012 | 26,256,525 | 5.204% |
| Amgen Inc | 255,017 | 26,057,637 | 5.165% |
| Johnson & Johnson | 290,367 | 25,555,200 | 5.065% |
| Abbott Laboratories | 640,821 | 24,229,442 | 4.803% |
| Merck & Co Inc | 515,253 | 23,294,588 | 4.617% |
| Pfizer Inc | 808,636 | 23,207,853 | 4.600% |
| Eli Lilly & Co | 407,969 | 22,446,454 | 4.449% |
| Santarus Inc | 913,511 | 20,188,593 | 4.002% |
| Actavis Inc | 144,734 | 18,402,928 | 3.648% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page